Pioglitazone Hydrochloride Tablet
Product Images NDC 50090-6393

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone Hydrochloride (NDC 50090-6393). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906393)

FDA Label Image

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)

Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)
The text describes Figure 1 of a 26-week study that evaluated mean change from baseline for HbAlc with varying doses (15mg, 30mg, and 45mg) compared to a placebo. The graph shows observed values, with the mean HbAlc decreasing over the course of the study for all dosage groups.*
FDA Label Image

Chemical Structure (Pioglitazone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.